Data / Drug companies / Chlorpromazine hydrochloride
Chlorpromazine hydrochloride: 27 companies and 107 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chlorpromazine hydrochloride is listed in the FDA National Drug Code Directory by 27 companies, with 107 products in commercial distribution. 107 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, sugar coated; injection, and the newest product started marketing on June 2, 2026.
The request: Get every company that lists chlorpromazine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 107
- Generic (ANDA) products
- 107 (100.0%)
- Application numbers
- 23
- Routes
- Oral, Intramuscular
- openFDA record search
- api.fda.gov
Companies that list chlorpromazine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| American Health Packaging | 9 | tablet, film coated; tablet, sugar coated | Generic drugs (ANDA) | June 2, 2026 |
| Remedyrepack Inc. | 8 | tablet, film coated; tablet, sugar coated | Generic drugs (ANDA) | February 26, 2025 |
| Zydus Lifesciences Limited | 7 | tablet, film coated; injection | Generic drugs (ANDA) | March 29, 2024 |
| Zydus Pharmaceuticals USA Inc. | 7 | tablet, film coated; injection | Generic drugs (ANDA) | March 29, 2024 |
| Novadoz Pharmaceuticals LLC | 6 | tablet, sugar coated; injection | Generic drugs (ANDA) | January 26, 2026 |
| Amneal Pharmaceuticals NY LLC | 5 | tablet, film coated | Generic drugs (ANDA) | September 12, 2018 |
| Aurobindo Pharma Limited | 5 | tablet | Generic drugs (ANDA) | April 25, 2025 |
| AvPAK | 5 | tablet, film coated | Generic drugs (ANDA) | February 14, 2020 |
| Chartwell RX, LLC | 5 | tablet, sugar coated | Generic drugs (ANDA) | February 5, 2022 |
| Glenmark Pharmaceuticals Inc., USA | 5 | tablet, film coated | Generic drugs (ANDA) | March 23, 2021 |
| Golden State Medical Supply, Inc. | 5 | tablet, coated | Generic drugs (ANDA) | January 22, 2021 |
| Lannett Company, Inc. | 5 | tablet, coated | Generic drugs (ANDA) | January 22, 2021 |
| Upsher-Smith Laboratories, LLC | 5 | tablet, film coated | Generic drugs (ANDA) | August 8, 2011 |
| Zameer Pharmaceuticals LLC | 5 | tablet, sugar coated | Generic drugs (ANDA) | February 5, 2022 |
| Advagen Pharma Ltd | 2 | concentrate | Generic drugs (ANDA) | October 10, 2025 |
| Camber Pharmaceuticals, Inc. | 2 | injection | Generic drugs (ANDA) | November 18, 2024 |
| Coupler LLC | 2 | tablet, sugar coated | Generic drugs (ANDA) | December 30, 2025 |
| Devatis, Inc. | 2 | injection | Generic drugs (ANDA) | November 1, 2024 |
| Eugia US LLC | 2 | injection | Generic drugs (ANDA) | July 7, 2020 |
| Fresenius Kabi USA, LLC | 2 | injection | Generic drugs (ANDA) | February 15, 2025 |
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | October 4, 2024 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection | Generic drugs (ANDA) | July 25, 1974 |
| NorthStar Rx LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 11, 2020 |
| Piramal Critical Care Inc | 2 | injection | Generic drugs (ANDA) | December 1, 2024 |
| Sandoz Inc | 2 | concentrate | Generic drugs (ANDA) | March 31, 2023 |
| Saptalis Pharmaceuticals, LLC. | 2 | concentrate | Generic drugs (ANDA) | March 4, 2026 |
| Henry Schein, Inc. | 1 | injection | Generic drugs (ANDA) | January 9, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 41 | 38.3% |
| Tablet, sugar coated | 24 | 22.4% |
| Injection | 21 | 19.6% |
| Tablet, coated | 10 | 9.3% |
| Concentrate | 6 | 5.6% |
| Tablet | 5 | 4.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 107 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phenothiazine | 107 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.